WHO ICTRP trial
Prevention of cartilage destruction in rheumatoid arthritis by etanercept…
JPRN-UMIN000001798 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000001798 |
|---|---|
| Public title | Prevention of cartilage destruction in rheumatoid arthritis by etanercept (PRECEPT study) |
| Scientific title | Prevention of cartilage destruction in rheumatoid arthritis by etanercept (PRECEPT study) - PRECEPT study |
| Primary sponsor | Team RA, Rheumatosurgery, Osaka City University Medical School |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not applicable |
| Countries | Japan |
| Conditions | Rheumatoid arthritis |
| Interventions | Injection of etanercept by 50 mg/week for one year Injection of etanercept by 25 mg/week for one year |
| Registration date | Mar 25, 2009 |
| Target size | 100 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: